Burning Rock Biotech annual net debt
2020
2021
2022
2023
2024
2025
Burning Rock Biotech Net Debt Growth & History (BNR)
Burning Rock Biotech's net debt was −$62.3M for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$62.3M | $1.8M | — |
| 2024 | 2024-12-31 | −$64.1M | $20.8M | — |
| 2023 | 2023-12-31 | −$84.9M | $39.0M | — |
| 2022 | 2022-12-31 | −$123.9M | $87.1M | — |
| 2021 | 2021-12-31 | −$211.0M | $78.3M | — |
| 2020 | 2020-12-31 | −$289.3M | — | — |
Burning Rock Biotech quarterly net debt
Q4.20
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −$62.3M | $1.8M | — |
| Q4 2024 | 2024-12-31 | −$64.1M | $20.8M | — |
| Q4 2023 | 2023-12-31 | −$84.9M | $39.0M | — |
| Q4 2022 | 2022-12-31 | −$123.9M | $87.1M | — |
| Q2 2022 | 2022-06-30 | −$159.9M | — | — |
| Q4 2021 | 2021-12-31 | −$211.0M | $78.3M | — |
| Q4 2020 | 2020-12-31 | −$289.3M | — | — |
Burning Rock Biotech net debt trends
Over the last five fiscal years, Burning Rock Biotech's net debt increased from −$289.3M to −$62.3M, a change of $227.1M. The latest reported quarter, Q4 2025, shows −$62.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗